Sirkisson, Suhina
Zikhali, Nelisiwe
Chang, Christina
Ndung’u, Thumbi
Sojane, Katlego
Ndlovu, Bongiwe
Funding for this research was provided by:
Bill and Melinda Gates Foundation ((OPP1066973, OPP1146433))
Gilead Sciences, Inc. (Grant ID #00406)
The International AIDS Vaccine Initiative (IAVI) t ((UKZNRSA1001), NIAID (R37AI067073),)
Harvard University Center for AIDS Research (P30 AI060354,)
Poliomyelitis Research Foundation ((PRF) (20/27))
European & Developing Countries Clinical Trials Partnership (TMA2020CDF-3183)
National Research Foundation Thuthuka Program (#129653)
Article History
Received: 2 December 2025
Accepted: 23 March 2026
First Online: 4 April 2026
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Biomedical Research and Ethics Committee of the University of KwaZulu-Natal (BF053/09 and BREC/00001996/2020; 01,2020), Monash University (2009001224) and the University of Western Australia (RA/4/1/2541).
: Informed consent was obtained from all subjects involved in the study.
: Not applicable.
: The authors declare no competing interests.